Ruth Gallily of the Hebrew University who works for the company and has been studying CBD for more than 12 years, said she has found that the substance has impressive anti-inflammatory qualities. She has been testing the effects of Tikun Olam’s CBD-enhanced cannabis on mice and expects clinical trials to begin in a few months.
Avidekel is a new strain of a plant that is already permitted for medical use so there is nothing stopping patients who are already being treated with marijuana from trying Avidekel. About 10 patients began using it in the past six months, Klein said.
“The cannabis plant, enriched with CBD, can be used for treating diseases like rheumatoid arthritis, colitis, liver inflammation, heart disease and diabetes,” she said, adding there are no side effects.
“It’s a huge advantage,” said one 35-year-old patient who asked not to be identified, “I can smoke during the day, function with a lot less pain and still be focused, work and drive. It is a great gift.”
The woman began suffering chronic pains after a tumor was removed from her spine. She began treatment with regular THC-containing marijuana eight months ago. Two months ago she started smoking Avidekel.
“The difference is huge. Before, I would only smoke at the end of the day and stay in pain.” Now, she said, with the highless marijuana “my life is so much better.”
Despite Avidekel’s highless benefit, Klein does not see regular marijuana disappearing any time soon. THC has its own unique effects that alleviate illness symptoms.
“Don’t worry, I think that cannabis with THC will still be (around),” he said.
By Maayan Lubell